Chief Science Officer
American Thrombosis and Hemostasis Network
New Orleans, Louisiana, United States
Dr. Tami Chrisentery-Singleton is the new Chief Science Officer for The American Thrombosis and Hemostasis Network (ATHN).
She was previously the Chief of Pediatric Hematology, and Director of the Hemophilia Treatment Center at the Mississippi Center for Advanced Medicine, and the Louisiana Center for Advanced Medicine. She received her MD from Louisiana State University - New Orleans, and then completed her pediatric residency at the University of Miami School of Medicine. Following residency, she completed pediatric hematology/oncology fellowship training at The Johns Hopkins University School of Medicine and the National Cancer Institute , where she developed a serious interest in disorders of coagulation. After her fellowship training, she was recruited to join the pediatric hematology/oncology faculty at LSU and Children’s Hospital of New Orleans. In 2010, Dr. Singleton accepted a position at Tulane University School of Medicine as Chief of Pediatric Hematology/Oncology, Director of the Sickle Cell Center of Southern Louisiana, and Associate Director of the Louisiana Center for Bleeding and Clotting Disorders.
Dr. Singleton has served as the principal investigator for many clinical trials, authored many publications and textbook chapters, and she has a special interest in gene therapy, sickle cell, congenital TTP and musculoskeletal ultrasound in hemophilia patients.
PB0323 - Preliminary Analysis of ATHN 16: Real-World Safety of Eptacog Beta
Sunday, June 25, 2023
18:30 – 19:30 ET